Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites.
about
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentNovel therapeutics for Alzheimer's disease: an updateUnified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyNeuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glassReactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic PlasticityEffects of age, dietary, and behavioral enrichment on brain mitochondria in a canine model of human agingHyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics.Mitochondrial-targeted fluorescent probes for reactive oxygen species.Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid.Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.A nutraceutical a day may keep the doctor away. Consumers are turning increasingly to food supplements to improve well-being when pharmaceuticals fail.Oxygen glucose deprivation in rat hippocampal slice cultures results in alterations in carnitine homeostasis and mitochondrial dysfunction.NT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the aged rat.Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.Frontiers in Alzheimer's disease therapeutics.Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics.Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain agingLipoamide Acts as an Indirect Antioxidant by Simultaneously Stimulating Mitochondrial Biogenesis and Phase II Antioxidant Enzyme Systems in ARPE-19 Cells.Modeling mitochondrial dysfunctions in the brain: from mice to men.Antioxidants in the canine model of human aging.Oxidative stress and aberrant signaling in aging and cognitive decline.Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease.Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice.Alpha-lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome.The dihydrolipoamide acetyltransferase is a novel metabolic longevity factor and is required for calorie restriction-mediated life span extension.Blueberry-enriched diet ameliorates age-related declines in NMDA receptor-dependent LTP(R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage.Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid.Mitochondria and reactive oxygen species.Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease.Altered skeletal muscle insulin signaling and mitochondrial complex II-III linked activity in adult offspring of obese mice.Chronic inhibition of PPAR-γ signaling induces endothelial dysfunction in the juvenile lambShort-term supplementation with acetyl-L-carnitine and lipoic acid alters plasma protein carbonyl levels but does not improve cognition in aged beagles.Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine.Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension.Consequences of oxidative stress in age-related macular degeneration.
P2860
Q22241837-330826FF-B005-426D-B1E5-868B4677FACFQ24620383-26F3F4BC-F3D6-4B9C-A30A-13E919585799Q26382049-76AFE9F1-8518-4DFF-88D2-CBE8FE4F52D3Q27015785-E1B0F8D2-AC17-40B4-90E2-6F6E78052DC9Q28070007-1E47C876-A786-4ED8-B4AA-F716305F4D56Q28111789-9E3ADA4F-20C4-48A9-B3C1-89ED8903183DQ28566589-EEAEBE79-8288-47F8-8086-D4E112DADD29Q30478356-80964680-F9F9-4DDA-92E0-79B3FFB78BFFQ33698018-EC1C59F5-BEE7-433D-8F46-53AECA100ABAQ33996663-85437C6F-24FB-4598-B7E0-A21313CE79E0Q34011426-E4C5725C-8D0A-4832-8B6F-2D0E821BB0B4Q34073939-EF12479B-25CE-4C60-9CD5-AB475E2C4BF9Q34360497-F3E335ED-A478-412B-ABEC-1EDE4952F436Q34415826-28AC43A2-696A-4E6A-8F0A-2CCA72D48171Q34460975-8BE368F8-029B-42D5-BE1F-9F32662B9B9CQ34507396-44AF2578-4DD5-461E-8ED7-49152E222390Q35086876-D2883D9D-3460-45FA-BB0A-DF308B29CAE6Q35116171-400F39CB-A482-4DD3-81F6-ADEEDCC6199CQ35359185-F68D49CC-5429-4A7D-8790-E3827E63A6BAQ35648531-92256F98-EFE5-49CE-8D22-DCFC13B1D012Q35754400-ACA55323-B764-4A1A-AF47-E964F4BE727CQ35795151-1FD76EAF-0573-4959-BE61-DC8B0CC7C0CCQ35987295-0867FAFD-A321-4D0F-9857-8DE451926EC0Q36212135-C1419461-9089-41C3-92B5-CEE49F9D1363Q36608618-909037CD-B3BF-4CD9-B269-0E7BED4C60A1Q36736338-84B311B7-53C5-4F41-8DA3-F916F1D6D640Q36737714-33C31632-5951-47E9-B715-2E9684A649F3Q36979399-A77263AB-9F88-413D-9D29-CC79BD923FF4Q37003856-4E786207-E482-495D-8CE5-E25B3101DDD3Q37003860-E4866455-ADE0-466F-BEE6-BB034D701D8BQ37278020-004B7483-BA6A-4900-A8CB-986FF029AC1BQ37334961-6626A4B5-7524-42B4-A60E-701F1F586AA8Q37337564-10FD7ECA-0757-4011-904B-79CB16E6AA57Q37414446-2113D96E-383E-4F0F-8309-6641CEF9079FQ37456323-1CC7DE61-45E6-4356-A887-56B004EC2AF5Q37465606-4142687F-A534-47D9-87C6-A3FF69B20B9EQ37465744-EB045385-D37C-439D-9A19-89B578C3D2BBQ37580731-7857A894-F686-409F-8416-B4D728DC4DDCQ37676063-16DDB659-9B89-48ED-B3DD-04545C9CB0F8Q38003229-3EA4E023-3D0E-45E5-B902-6F8939C4AA0B
P2860
Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@ast
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@en
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@nl
type
label
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@ast
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@en
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@nl
prefLabel
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@ast
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@en
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@nl
P2093
P2860
P1476
Delaying brain mitochondrial d ...... antioxidants and metabolites.
@en
P2093
Bruce N Ames
Hani Atamna
Hirohiko Kuratsune
Jiankang Liu
P2860
P304
P356
10.1111/J.1749-6632.2002.TB02090.X
P407
P577
2002-04-01T00:00:00Z